维普期刊资源整合服务平台（V6.5）

103篇 您的检索式：作者名="Bubley"

选中清除导出查看参考文献查看引证文献引用追踪共6页首页上一页第1页下一页末页 /6 跳转

	题名	作者	年代	出处	被引量
1	Eligibility and response guidelines for phase Ⅱ clinical trials in androgen-independent prostate cancer:recommendations from the Prostate-Specific Antigen Working Group显示文摘	Bubley GJ Carducci M Dahut W	1999	J Clin Oncol1999，17，：	1
2	Mutation of the androgen receptor gene in metastatic androgen-independent prostate cancer 显示文摘	Taplin ME Bubley GJ Shuster TD	1995	New Engl J Med1995，332，：	1
3	Squamous cell car- cinoma of the renal pelvis with inferior vena caval extension 显示文摘	Kibel US Downs TM Bubley GJ	2003	J Urol2003，72，6：	1
4	Hormonal predictors of prostate cancer:a meta-analysis显示文摘	Shaneyfelt T Husein R Bubley G	2000	J Clin Oncol2000，18，4：	1
5	Eligibility and response guidelines for phase Ⅱ clinical trials in androgen-independent prostate cancer: recommendations from the Prostate-Specific Antigen Working Group 显示文摘	Carducci M Dahut W	1999	J Clin Oncol1999，17，11：	1
6	The idiopathic hypereosinophilic syndrome显示文摘	Weller PF Bubley GJ	1994	Blood1994，83，10：	1
7	Hormonal predictors of prostate cancer: a meta-a4nalysis显示文摘	Shaneyfelt T Husein R Bubley G	2000	Clin Oncol2000，8，4：	1
8	Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer显示文摘	TAPLIN ME BUBLEY GJ SHUSTER TD	1995	N Engl J Med1995，332，21：	1
9	Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer显示文摘	Stanbrough M Bubley G J Ross K Golub T R Rubin M A Penning T M	2006	Cancer Res2006，66，：	1
10	Selection for androgen receptor mutations in prostate cancers treated with androgen antagonist显示文摘	TAPLIN ME BUBLEY GJ KO YJ	1999	CancerRes1999，59，11：	1
11	Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer显示文摘	Taplin M E Bubley G J Shuster T D	1995	N Engl J Med1995，332，21：	1
12	Biology of prostate-specific antigen显示文摘	BALK SP KO Y J BUBLEY GJ	2003	J Clin Oncol2003，21，2：	1
13	Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer显示文摘	STANBROUGH M BUBLEY GJ ROSS K	2006	Cancer Res2006，66，5：	1
14	The idiopathic hypereosinophilic syndrome 显示文摘	Weller PF Bubley GJ	1994	Blood1994，83，：	1
15	The idiopathic hypereosinophilic syndrome 显示文摘	Weller PF Bubley GJ	1994	Blood1994，83，10：	1
16	The idiopathic hypereosinophilic syndrome 显示文摘	Weller PF Bubley GJ	1994	Blood1994，83，10：	1
17	Eligibility and response guidelines for phase Ⅱ clinical trials in androgenindependent prostate cancer:recommendations from the Prostate-Specific Antigen Working Group显示文摘	Carducci M Dahut W	1999	J Clin Oncol1999，17，：	1
18	Biology of prostate-specific antigen显示文摘	BALK S P KO Y J BUBLEY G J	2003	J Clin Oncol2003，21，：	1
19	The idiopathic hypereosinophilic syndrome显示文摘	Weller PF Bubley GJ	1994	Blood1994，83，10：	1
20	Eligibility and response guidelines for phase 1I clinical trials in androgen independent prostate cancer: recommendations t'rom the prostate-specific antigen working group显示文摘	Bubley GJ Carducci M Dahut W	1999	J Clin Oncol1999，，：	1

返回顶部每页显示：

共6页首页上一页第1页下一页末页 /6 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示